96 related articles for article (PubMed ID: 9020022)
41. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.
Coustry F; Hu Q; de Crombrugghe B; Maity SN
J Biol Chem; 2001 Nov; 276(44):40621-30. PubMed ID: 11514576
[TBL] [Abstract][Full Text] [Related]
42. Further characterization of the c-mos transcript and its cell cycle specific expression in NIH3T3 cells.
Gao C; Arlinghaus RB; Singh B
Oncogene; 1996 Apr; 12(7):1571-6. PubMed ID: 8622874
[TBL] [Abstract][Full Text] [Related]
43. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs.
Joshi AA; Wu Z; Reed RF; Suttle DP
Mol Pharmacol; 2003 Feb; 63(2):359-67. PubMed ID: 12527807
[TBL] [Abstract][Full Text] [Related]
44. c-Myb trans-activates the human DNA topoisomerase IIalpha gene promoter.
Brandt TL; Fraser DJ; Leal S; Halandras PM; Kroll AR; Kroll DJ
J Biol Chem; 1997 Mar; 272(10):6278-84. PubMed ID: 9045645
[TBL] [Abstract][Full Text] [Related]
45. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells.
Woessner RD; Mattern MR; Mirabelli CK; Johnson RK; Drake FH
Cell Growth Differ; 1991 Apr; 2(4):209-14. PubMed ID: 1651102
[TBL] [Abstract][Full Text] [Related]
46. Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAF1/CIP1/SDI1).
Zhu H; Chang BD; Uchiumi T; Roninson IB
Cell Cycle; 2002 Jan; 1(1):59-66. PubMed ID: 12429910
[TBL] [Abstract][Full Text] [Related]
47. Induction of G2 arrest and gene expression by 2-aminopurine in human U937 promonocyte-macrophage cells.
Maio JJ; Graham GJ; Brown FL
Exp Cell Res; 1995 Aug; 219(2):442-8. PubMed ID: 7641795
[TBL] [Abstract][Full Text] [Related]
48. Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamide.
Hochhauser D; Kotecha M; O'hare C; Morris PJ; Hartley JM; Taherbhai Z; Harris D; Forni C; Mantovani R; Lee M; Hartley JA
Mol Cancer Ther; 2007 Jan; 6(1):346-54. PubMed ID: 17237293
[TBL] [Abstract][Full Text] [Related]
49. Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase IIalpha gene.
Falck J; Jensen PB; Sehested M
J Biol Chem; 1999 Jun; 274(26):18753-8. PubMed ID: 10373491
[TBL] [Abstract][Full Text] [Related]
50. Cell cycle-dependent regulation of the cyclin B1 promoter.
Hwang A; Maity A; McKenna WG; Muschel RJ
J Biol Chem; 1995 Nov; 270(47):28419-24. PubMed ID: 7499347
[TBL] [Abstract][Full Text] [Related]
51. Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy.
Wang Y; Coffey RJ; Osheroff N; Neufeld KL
PLoS One; 2010 Apr; 5(4):e9994. PubMed ID: 20368985
[TBL] [Abstract][Full Text] [Related]
52. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.
Stros M; Polanská E; Struncová S; Pospísilová S
Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331
[TBL] [Abstract][Full Text] [Related]
53. Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells.
Isaacs RJ; Harris AL; Hickson ID
J Biol Chem; 1996 Jul; 271(28):16741-7. PubMed ID: 8663303
[TBL] [Abstract][Full Text] [Related]
54. [The regulation of calmodulin in the cell cycle].
Jin S; Yin L; Wang DS; Liu HT
Shi Yan Sheng Wu Xue Bao; 1995 Jun; 28(2):121-9. PubMed ID: 7571946
[TBL] [Abstract][Full Text] [Related]
55. Expression of topoisomerase IIalpha in the G0/G1 cell cycle phase of fresh leukemic cells.
Uggla B; Möllgård L; Ståhl E; Mossberg LL; Karlsson MG; Paul C; Tidefelt U
Leuk Res; 2001 Nov; 25(11):961-6. PubMed ID: 11597731
[TBL] [Abstract][Full Text] [Related]
56. The suppression of the synthesis of a nuclear protein in cells blocked in G2 phase: identification of NP-170 as topoisomerase II.
Goswami PC; Hill M; Higashikubo R; Wright WD; Roti Roti JL
Radiat Res; 1992 Nov; 132(2):162-7. PubMed ID: 1332112
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.
Wang Q; Zambetti GP; Suttle DP
Mol Cell Biol; 1997 Jan; 17(1):389-97. PubMed ID: 8972219
[TBL] [Abstract][Full Text] [Related]
58. The dynamics of DNA topoisomerase IIalpha in living cells.
Daum JR; Mo YY; Gorbsky GJ
Methods Mol Biol; 2009; 582():233-44. PubMed ID: 19763954
[TBL] [Abstract][Full Text] [Related]
59. Expression of GCF protein is dependent on the cell cycle.
Mao P; Takimoto M; Wei G; Sakai N; Senmaru N; Fujita H; Kuzumaki N
Nucleic Acids Symp Ser; 1997; (37):119-20. PubMed ID: 9586028
[TBL] [Abstract][Full Text] [Related]
60. Developmental and hormonal regulation of type II DNA topoisomerase in rat testis.
Bakshi RP; Galande S; Bali P; Dighe R; Muniyappa K
J Mol Endocrinol; 2001 Jun; 26(3):193-206. PubMed ID: 11357056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
